[144] MongoDB, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 filing by an insider related to MongoDB, Inc. (MDB) discloses a proposed sale of 664 common shares with an aggregate market value of $209,565.04, scheduled approximately for 09/02/2025 on NASDAQ. The shares were originally acquired on 10/01/2009 as a VC investment and paid for in cash. The filing also lists recent 10b5-1 sales on 08/28/2025 totaling 8,004 shares for gross proceeds of $2,400,000 (6,668 shares by Charles M. Hazard Jr. for $2,000,400 and 1,336 shares by The Narragansett Bay Childrens Trust for $400,800). The filer certifies under Rule 144 statements about material nonpublic information and references any applicable 10b5-1 trading plan.

Positive

• Proper regulatory compliance: The filer submitted a Rule 144 notice with acquisition details and 10b5-1 disclosures.
• Transparency on provenance: Acquisition date (10/01/2009) and cash payment are disclosed, clarifying the holding origin.

Negative

• Insider selling activity: Recent 10b5-1 sales on 08/28/2025 totaled 8,004 shares for $2,400,000 in gross proceeds.

Insights

Securities Analyst

TL;DR: Insider sale notice for a small block of shares; recent 10b5-1 activity shows modest monetization by related parties.

The filing shows a proposed Rule 144 sale of 664 shares valued at about $209.6k and discloses 10b5-1 sales on 08/28/2025 totaling 8,004 shares for $2.4M in gross proceeds. Relative to the 81,356,893 shares outstanding noted in the filing, these transactions represent a de minimis percentage of the float and are unlikely to change company control or capital structure. The inclusion of acquisition details (10/01/2009 VC investment) and the 10b5-1 sales offers transparency on the provenance of shares and timing. For investors, this is routine insider liquidity rather than evidence of company operational change.

Corporate Governance Expert

TL;DR: Properly filed Rule 144 notice with 10b5-1 disclosures; governance procedures appear followed.

The filer affirms the absence of undisclosed material adverse information and references Rule 10b5-1 trading instructions where applicable. The documentation of acquisition date, payment method, and relation to the issuer aligns with regulatory expectations. The recent 10b5-1 sales by named parties are disclosed with gross proceeds, supporting compliance and transparency. No departures from standard disclosure or governance controls are apparent within this filing's content.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	664	209565.04	81356893	09/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2009	VC Investment	Issuer			664	10/01/2009	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CHARLES M HAZARD JR. 1633 Broadway, 38th Floor New York NY 10019	Common	08/28/2025	6668	2000400.00
10b5-1 Sales for THE NARRAGANSETT BAY CHILDRENS TRUST U/A DTD 12/11/2004 1633 Broadway, 38th Floor New York NY 10019	COMMON	08/28/2025	1336	400800.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for MDB disclose about the proposed sale?

The form discloses a proposed sale of 664 common shares valued at $209,565.04, with an approximate sale date of 09/02/2025 on NASDAQ.

Who previously sold shares related to this filing and what were the proceeds?

10b5-1 sales on 08/28/2025 show 6,668 shares sold by Charles M. Hazard Jr. for $2,000,400 and 1,336 shares by The Narragansett Bay Childrens Trust for $400,800.

When were the securities being sold originally acquired?

The shares were acquired on 10/01/2009 as a VC investment and paid for in cash.

How many shares outstanding does the filing list?

The filing lists 81,356,893 shares outstanding for the issuer.

Does the filing state whether the seller knows of material nonpublic information?

Yes, the person for whose account the securities are to be sold represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.